DNM1L and amyotrophic lateral sclerosis: One example is Mdivi-1, a Drp-1 inhibitor that showed protective effects by mitigating mitochondrial dysfunction and synaptic impairment in HD [242] and by improving mitochondrial morphology and survival in ALS mouse models [243].